221
Views
15
CrossRef citations to date
0
Altmetric
Review

Semliki Forest virus vectors for gene therapy

Pages 771-777 | Published online: 03 Mar 2005

Bibliography

  • LUNDSTROM K: Latest development of viral vectors for gene therapy. Trends Biotechnol (2003) 21:117–122.
  • STRAUSS JH, STRAUSS EG: The alphaviruses: gene expression, replication, and evolution. Microbial. Rev (1994) 58:491–562.
  • EHRENGRUBER MU, HENNOU S, BUELER H, NAIM HY, DEGLON N, LUNDSTROM K: Gene transfer into neurons from hippocampal slices by recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus and measles virus. MM. Cell Neurosci. (2001) 17:855–871.
  • LILJESTROM P, GAROFF H: A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (1991) 9:1356–1361.
  • LUNDSTROM K: Alphaviruses as tools in neurobiology and gene therapy. Recept. Signal Transduct. Res. (1999) 19:673–686.
  • XIONG C, LEVIS R, SHEN P, SCHLESINGER S, RICE CM, HUANG HV: Sindbis virus: an efficient broad host range vector for gene expression in animal cells. Science (1989) 243:1188–1191.
  • DAVIS NL, BROWN KW, JOHNSTON RE: In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology (1989) 171:189–204.
  • LUNDSTROM K, PRALONG W, MARTINOU J-C: Anti-apoptotic effect of Bc1-2 overexpression in RIN cells infected with Semliki Forest virus. Apoptosis (1997) 2:189–191.
  • HARDY PA, MAZZINI MJ, SCHWEITZER C, LUNDSTROM K, GLODE LM: Recombinant Semliki Forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vim. Int. J. MM. Med. (2000) 5:241–245.
  • LOIMAS S, TOPPINEN MR, VISAKORPI T, JANNE J, WAHLFORS J: Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy. Cancer Gene The]: (2001) 8:137–144.
  • CULVER KW, RAM Z, WALLBRIDGE S,ISHII H, OLDFIELD EH, BLAESE RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 256:1550–1552.
  • ASSELIN-PATUREL C, LASSAU N, GUINEBRETIERE J-M et al.: Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Tiler. (1999) 6:606–615.
  • •First description of intraturnoural injection of recombinant SFV particles demonstrating tumour regression.
  • COLMENERO P, CHEN M, CASTANOS-VELEZ E, LILJESTROM P, JONDAL M: Immunotherapy with recombinant SFV-replicons expressing the P185A tumor antigen or IL-12 induces tumor regression. Int. J. Cancer (2002) 98:554–560.
  • MURPHY A-M, MORRIS-DOWNES MM, SHEAHAN BJ, ATKINS GJ: Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Tiler. (2000) 7:1477–1482.
  • MURPHY AM, SHEAHAN BJ, ATKINS G: Induction of apoptosis in Bcl-2-expressing rat prostate cancer cells using the Semliki Forest virus vector. Int. J. Cancer (2001) 94:572–578.
  • KLIMP AH, VAN DER VAART E, LANSINK PO et al: Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF. Gene Ther: (2001) 8:300–307.
  • •Peritoneal administration of SFV expressing a therapeutic gene, GM-CSE
  • LI K-J, GAROFF H: Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Proc. Natl. Acad. Sci. USA (1996) 93:11658–11663.
  • LI K-J, GAROFF H: Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors. Proc. Natl. Acad. Sci. USA (1998) 95:3650–3654.
  • WAHLFORS JJ, XANTHOPOULOS KG, MORGAN RA: Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Hum. Gene Ther. (1997) 8:2031–2041.
  • WAHLFORS JJ, MORGAN RA: Production of minigene-containing retroviral vectors using an alphavirus/ retrovirus hybrid vector system. Hum. Gene The]: (1999) 10:1197–1206.
  • LEBEDEVA I, FUJITA K, NIHRANE A, SILVER J: Infectious particles derived from Semliki Forest virus vectors encoding murine leucemia virus envelope. J. Vim/. (1997) 71:7061–7067.
  • OHNO K, SAWAI K, IRMA Y, LEVIN B, MERUELO D: Cell-specific targeting of Sindbis virus vectors displaying IgG binding domains of protein A. Nat. Biotechnol (1997) 15:763–767.
  • GARDNER JP, FROLOV I, PERRI S et al: Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. Virol (2000) 74: 11849-11857.
  • ••Demonstration of targeting Sindbisinfection to dendritic cells by introduction of a single point mutation in the E2 envelope protein gene.
  • LUNDSTROM K, BOULIKAS T: Breakthrough in cancer therapy: encapsulation of drugs and viruses. Curr: Drug Disc. (2002) Nov:19–23.
  • ••Liposome encapsulation of SFV particles for tumour targeting after systemic administration, which allowed conducting a Phase I clinical trial on patients with advanced kidney carcinoma and melanoma.
  • LUNDSTROM K: Alphavirus-based vaccines. Carr: Opin. Mol. Ther: (2002) 4:28–34.
  • YING H, ZAKS TZ, WANG R-F et al: Cancer gene therapy using self-replicating RNA vaccine. Nat. Med. (1999) 5:823–827.
  • ••Demonstration of both therapeutic andprophylactic effects on tumours after administration of naked SFV RNA in mice.
  • COLMENERO P, LILJESTROM P, JONDAL M: Induction of P185 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene. Gene The]: (1999) 6: 1728-1733.
  • DAEMEN T, REGTS J, HOLTROP M, WILSCHUT J: Immunization strategy against cervical cancer involving an aplhavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Gene Ther: (2002) 9:85–94.
  • YAMANAKA R, ZULLO SA, TANAKA R, BLAESE M, XANTHOPOULOS KG: Enhancement of antitumor response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA. J. Neurosurg. (2001) 94:474–481.
  • MATHIOT CC, GRIMAUD G, GARRY P: An outbreak of human Semliki Forest virus infections in Central African Republic. Am. .1. Bop. Med. Hyg. (1990) 42:386–393.
  • BERGLUND P, SJOBERG M, GAROFF H, ATKINS GJ, SHEAHAN BJ, LILJESTROM P: Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (1993) 11:916–920.
  • SMERDOU C, LILJESTROM P: Two-helper RNA system for production of recombinant Semliki Forest virus particles. Virol (1999) 73:1092–1098.
  • POLO JM, BELLI BA, DRIVER DA et al: Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors. Proc. Nati Acad. ScL USA (1999) 96:4598–4603.
  • ••Establishment of a packaging cell line forproduction of Sindbis particles containing recombinant Sindbis or SFV RNA.
  • AGAPOV EV, FROLOV I, LINDENBACH BD, PRAGAI BM, SCHLESINGER S, RICE CM: Non-cytopathogenic Sindbis RNA vectors for heterologous gene expression. Proc. Nati Acad. Sci. USA (1998) 95:12989–12994.
  • BOORSMA M, NIEBA L, KOLLER D, BACHMANN ME BAILEY JE, RENNER WA: A temperature-regulated replicon-based DNA expression system. Nat. Biotechnol (2000) 18:429–432.
  • •Introduction of two point mutations generated a less cytotoxic cold-inducible Sindbis DNA plasmid vector applicable to cDNA expression cloning and expression of toxic proteins.
  • LUNDSTROM K, ROTMANN D, HERMANN D, SCHNEIDER EM, EHRENGRUBER MU: Novel mutant Semliki Forest virus vectors: gene expression and localization studies in neuronal cells. Histochem. Cell Biol. (2001) 115:83–91.
  • LUNDSTROM K, ABENAVOLI A, MALGAROLI A, EHRENGRUBER MU: Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitività for long-term enhancement of transgene expression. Ma The]: (2003) 7:202–209.
  • •Novel, less cytotoxic SFV vectors with substantially prolonged survival of infected host cells.
  • PERRI S, DRIVER DA, GARDNER JP et al.: Replicon vectors derived from Sindbis virus and Semliki Forest virus that established persistent replication in host cells. Virol (2000) 74:9802–9807.
  • •Replication-persistent Sindbis and SFV vectors generated for extended duration of transgene expression.
  • EHRENGRUBER MU, RENGGLI M, RAINETEAU 0 et al.: Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner. J. Neurovirol (2003) 9:16–28.
  • VAHAKOSKELA MJ, TUITTILA MT, NYGARDAS PT et al.: A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus. Neurovirol (2003) 9:1–15.
  • LUNDSTROM K: Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochlin. Biophys. Acta (2003) 1610:90–96.
  • EHRENGRUBER MU, LUNDSTROM K, SCHWEITZER C et al.: Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc. Natl. Acad. Sci. USA (1999) 96:7041–7046.
  • LUNDSTROM K, RICHARDS JG, PINK JR et al.: Efficient in vivo expression of a reporter gene in rat brain after injection of replication-deficient Semliki Forest virus. Gene Ther. Ma Biol. (1999) 3:15–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.